参考文献/References:
[1]. Weiford BC, Subbarao VD, Mulhern KM. Non-compaction of the ventricular myocardium[J]. Circulation,2004,109:2965-2971.
[2].Engberding R, Bender F. Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography: persistence of isolated myocardial sinusoids[J]. Am J Cardiol,1984,53(11):1733-1734.
[3].Elliott P. The 2006 American Heart Association classification of cardiomyopathies is the gold standard[J]. Circ Heart Fail,2008,1(1):77-79.
[4].Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases[J]. Eur Heart J,2008,29(2):270-276.
[5].Jenni R, Oechslin EN, Van der Loo B. Isolated ventricular non-compaction of the myocardium in adults[J]. Heart,2007, 93(1):11-15.
[6].Val-Bernal JF, Garijo MF, Rodriguez-Villar D, et al. Non-compaction of the ventricular myocardium: a cardiomyopathy in search of a path oanatomical definition[J]. Histol Histopathol, 2010, 25(4):495-503.
[7].Oechslin E, Jenni R. Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?[J].Eur Heart J, 2011,32(12):1446-1456.
[8].Chin TK, Perloff JK, Williams RG, et al. Isolated non-compaction of left ventricular myocardium. A study of eight cases[J]. Circulation, 1990,82 (2):507-513.
[9].Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long- term follow-up of 34 adults with isolated left ventricular non-compaction: a distinct cardiomyopathy with poor prognosis[J]. J Am Coll Cardiol, 2000,36(2):493-500.
[10].Stollberger C,Finsterer J. Left ventricular hypertrabeculation/non-compaction in juvenile neuronal ceroid lipofuscinosis [J]. Rinsho Shinkeigaku,2015,55(3):185.
[11].Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia[J]. N Engl J Med, 2003, 348(17):1639-1646.
[12].Pignatelli RH, McMahon CJ, Dreyer WJ, et al. Clinical characterization of left ventricular non-compaction in children: a relatively common form of cardiomyopathy[J]. Circulation, 2003, 108(21):2672-2678.
[13].Stollberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/non- compaction and association with additional cardiac abnormalities and neu- romuscular disorders[J]. Am J Cardiol,2002, 90(8):899-902.
[14].Lachhab A, Doghmi N, Elfakir Y, et al. Insights from magnetic resonance imaging of left ventricular non- compaction in adults of North African descent[J]. Int Arch Med, 2012,5:10.
[15].Klaassen S, Probst S, Oechslin E, et al. Mutations in sarcomere protein genes in left ventricular non- compaction[J]. Circulation,2008,117(22):2893-2901.
[16].Dellefave LM, Pytel P, Mewborn S, et al. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation [J]. Circ Cardiovasc Genet ,2009,2(5):442-449.
[17].Ichida F.Left ventricular noncompaction[J]. Circ J, 2009,73(1):19-26.
[18].Caliskan K, Kardos A, Szili-Torok T. Empty handed: a call for an international registry of risk stratification to reduce the “sudden-ness” of death in patients with non-compaction cardiomyopathy[J]. Europace, 2009,11(9):1138-1139.
[19].Sparrow P, Merchant N, Provost Y, et al. Cardiac MRI and CT features of inheritable and congenital conditions associated with sudden cardiac death[J]. Eur Radiol,2009,19(2):259-270.
[20]. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging [J]. J Am Coll Cardiol, 2005,46 (1):101-105.
[21].Jacquier A, Thuny F, Jop B, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction[J]. Eur Heart J, 2010, 31(9):1098-1104.
[22].Grothoff M, Pachowsky M, Hoffmann J, et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies[J]. Eur Radiol, 2012, 22 (12):2699-2709.
[23].Choi Y, Kim S M, Lee SC , et al. Quantification of left ventricular trabeculae using cardiovascular magnetic resonance for the diagnosis of left ventricular non- compaction: evaluation of trabecular volume and refined semi-quantitative criteria[J]. J Cardiovasc Magn Res, 2016, 18( 1): 24 .
[24].Vogel-Claussen J, Rochitte CE, Wu KC. Delayed enhancement MR imaging : utility in myocardial assessment[J]. RadioGraphics,2006,26(3):795-810 .
[25].Belloni E, de Cobelli F, Esposito A, et al. MRI of cardiomyopathy[J]. AJR Am J Roentgenol, 2008,191(6):1702-1710.
[26].Cummings KW, Bhalla S, Javidan Nejad C, et al. A pattern-based approach to assessment of delayed enhancement in non-ischemic cardiomyopathy[J]. Radiographics, 2009, 29(1):89-103.
[27].Nucifora G, Aquaro GD, Pingitore A, et al. Myocardial brosis in isolated left ventricular non-compaction and its relation to disease severity[J]. Eur J Heart Fail, 2011,13(2):170-176.
[28].Araujo-Filho JAB, Assuncao AN Jr, Tavares de Melo MD , et al. Myocardial T1 mapping and extracellular volume quantification in patients with left ventricular non-compaction cardiomyopathy [J].Eur Heart J Cardiovasc Imaging,2018,19(8):888-895.
[29].Uribe S , Cadavid L , Hussain T , et al. Cardiovascular magnetic resonance findings in a pediatric population with isolated left ventricular non-compaction[J]. J Cardiovasc Magn Reson, 2012,14:9 .
[30].Cheng H , Lu M , Hou C , et al. Comparison of cardiovascular magnetic resonance characteristics and clinical consequences in children and adolescents with isolated left ventricular non-compaction with and without late gadolinium enhancement[J]. J Cardiovasc Magn Reson, 2015,17:44 .
[31].Yun H, Zeng M, Jin H, et al. Isolated non-compaction of ventricular myocardium: a magnetic resonance imaging study of 11 patients[J]. Korean J Radiol, 2011,12(6):686-692.
[32].Fazio G, Lunetta M, Grassedonio E, et al. Non- compaction of the right ventricle[J]. Pediatr Cardiol, 2010, 31(4):576-578.
相似文献/References:
[1]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(5):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[2]徐源蔚 陈玉成.心脏磁共振在检测自身免疫性风湿疾病心脏受累中的应用进展[J].心血管病学进展,2019,(5):676.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.005]
XU Yuanwei,CHEN Yucheng.Advances in the Application of Cardiac Magnetic Resonance in Detecting Cardiac Involvement in Autoimmune Rheumatic Disease[J].Advances in Cardiovascular Diseases,2019,(5):676.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.005]
[3]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[4]冯泽豪 姜萌 卜军.心脏磁共振评价化疗所致心肌损伤的研究进展[J].心血管病学进展,2019,(5):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
FENG Zehao,JIANG Meng,PU Jun.Cardiovascular Magnetic Resonance for Detection of Myocardial Impairments Caused by Chemotherapy[J].Advances in Cardiovascular Diseases,2019,(5):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
[5]金荣杰 徐勇 邓珏琳 沈明志.应用心脏磁共振评估前列地尔对ST段抬高型心肌梗死患者心肌灌注的影响[J].心血管病学进展,2020,(10):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
JIN RongjieXU YongDENG JuelinSHEN Mingzhi.Effect of Alprostadil on Myocardial Perfusion of Patients with ST Segment Elevation Myocardial Infarction Directly Receiving Percutaneous Coronary Intervention Assessed with Cardiac Magnetic Resonance[J].Advances in Cardiovascular Diseases,2020,(5):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
[6]张宁 王嫱.心脏磁共振评估特发性炎症性肌病患者心脏受累的研究进展[J].心血管病学进展,2020,(11):1145.[doi:10.16806/j.cnki.issn.1004-3934.20.11.000]
ZHANG Ning,WANG Qiang.Advances in Evaluating Cardiac Involvement in Idiopathic Inflammatory Myopathy by Cardiac Magnetic Resonance[J].Advances in Cardiovascular Diseases,2020,(5):1145.[doi:10.16806/j.cnki.issn.1004-3934.20.11.000]
[7]陈小玲 陈玉成.肺高压心肌纤维化磁共振评价及临床意义[J].心血管病学进展,2021,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.010]
CHEN Xiaoling,CHEN Yucheng.Cardiac Magnetic Resonance Evaluation and the Clinical Value of Myocardial Fibrosis in Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2021,(5):135.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.010]
[8]尹丽丹 蒲守芳 何娟 陈玉成.右心室评价方法及其临床应用[J].心血管病学进展,2021,(6):521.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.011]
YIN Lidan,PU Shoufang,HE Juan,et al.The Methods to Evaluation of Right Ventricular and its Clinical Application[J].Advances in Cardiovascular Diseases,2021,(5):521.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.011]
[9]武志刚 孙佳莉 王巍.基于心脏磁共振成像的肥厚型心肌病患者早期峰值充盈率与舒张功能相关性的研究[J].心血管病学进展,2021,(7):658.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.020]
WU Zhigang,SUN Jiali,WANG Wei.Correlation Between Early Peak Filling Rate and Diastolic Function in Patients with Hypertrophic Cardiomyopathy Based on Cardiac Magnetic Resonance Imaging[J].Advances in Cardiovascular Diseases,2021,(5):658.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.020]
[10]蒲华霞 彭礼清.系统性红斑狼疮心脏受累的MRI评价进展[J].心血管病学进展,2021,(8):716.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.011]
PU huaxia,PENG Liqing.Magnetic Resonance Imaging in the Evaluation of Cardiac Involvement in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2021,(5):716.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.011]